Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

DES Home | For Consumers | For Health Care Providers
For DES Update Partners | Contact Us
DES Update: Health Care Providers
DES Update: Health Care Providers

Notice! Content may be out of date
The following content is no longer maintained and may be out of date. Persons with disabilities having difficulty accessing the information on this page may contact cdcinfo@cdc.gov for assistance. Please view the Updated Bibliographies on the Updated Bibliographies page for updated information on this topic.



 Health Care Providers Home
 Information to Identify and Manage DES Patients
 Supplemental DES Materials for Nurses
 Pharmacology
 DES Brand Names
 Resources and Educational Tools
 DES References
 References By Number
 References By Topic

Email this page
Order DES materials
Image of a book with a page being turned  DES References
Health Care Providers Home > DES References > 201 - 297
DES References 201 - 297

References By Number

 References 1 - 100
 References 101 - 200
 References 201 - 297

201. Conley GR, Sant GR, Ucci AA, Micheson HD. Seminoma and epididymal cysts in a young man with known diethylstilbestrol exposure in utero. JAMA 1983;249:1325-6.

202. Cosgrove MD, Benton B, Henderson BE. Male genitourinary abnormalities and maternal diethylstilbestrol. J Urol 1977;117(2):220-2.

203. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 1983;71:1151-5.

204. Driscoll SG, Taylor SH. Effects of prenatal maternal estrogen on the male urogenital tract. Obstet Gynecol 1980;56(5):537-42.

205. Gershman ST, Stolley PD. A case-control study of testicular cancer using Connecticut Tumor Registry data. Int J Epidemiol 1988;17:738-42.

206. Gill WB, Schumacher GFB, Bibbo M, Straus FH, Schoenberg HW. Association of diethylstilbestrol exposure in utero with cryptochidism, testicular hypoplasia and semen abnormalities. J Urol 1979;122:36-9.

207. Gill WB, Schumacher GFB, Bibbo M. Structural and functional abnormalities in the sex organs of male offspring of mothers treated with diethylstilbestrol (DES). J Reprod Med 1976;16(4):147-53.

208. Gill WB, Schumacher GFB, Bibbo M. Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero. J Urol 1977;117:477-80.

209. Gill WB, Schumacher GFB, Hubby MM, et al. Male genital tract changes in humans following intrauterine exposure to diethylstilbestrol [review]. In: Herbst AL, Bern HA, editors. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme-Stratton, Inc.; 1981. Chapter 8.

210. Goldberg J, Falcone T. Effect of diethylstilbestrol on reproductive function. Fertil Steril 1999;72:1-7.

211. Goy RB, McEwen BS. Sexual differentiation of the brain. Cambridge (MA): The MIT Press; 1980.

212. Herbst AL. Diethylstilbestrol and other sex hormones during pregnancy [review]. Obstet Gynecol 1981;58(Suppl):S35-S40.

213. Hembree WC, Nagler HM, Fang JS, Myles EL, Jagiello GM. Infertility in a patient with abnormal spermatogenesis and in utero DES exposure [case report]. Int J Fert 1988;33(3):173-7.

214. Henderson BE, Benton B, Jing J, Yu MC, Pike MC. Risk factors for cancer of the testis in young men. Int J Cancer 1979;23:598-602.

215. Henderson BE, Benton B, Cosgrove M, Baptista J, Aldrich J, Townsend D. Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics 1976;58(4):505-7.

216. Hinman F Jr. Unilateral abdominal cryptorchidism. J Urol 1979;122:71-5.

217. Leary FJ, Resseguie LJ, Kurland LT, O'Brien PC, Emslander RF, Noller K. Males exposed in utero to diethylstilbestrol. JAMA 1984;525(21):2984-9.

218. Loughlin JE, Robboy SJ, Morrison AS. Risk factors for cancer of the testis [letter to the editor]. N Engl J Med 1980;303(2):112-3.

219. McLachlan JA, Newbold RR, Li S, Negishi M. Are estrogens carcinogenic during development of the testes? APMIS 1998;106(1):240-4.

220. McLachlan JA. Rodent models for perinatal exposure to diethylstilbestrol and their relation to human disease in the male. In: Herbst AL, Bern HA, editors. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme-Stratton, Inc.; 1981.

221. McLachlan et al. Science. 1975;190:991-2.

222. Moss A, Osmond D, Bacchetti P, Torit FM, Gurgin V. Hormonal risk factors in testicular cancer: a case-control study. Am J Epidemiol 1986;124:39-52.

223. Newbold RR, Bullock BC, McLachlan JA. Lesions of the rete testis in mice exposed prenatally to diethylstilbestrol. Cancer Res 1985;45:5145-8.

224. Newbold RR, Bullock BC, McLachlan JA. Testicular tumors in mice exposed in utero to diethylstilbestrol. J Urol 1987;138:1446-50.

225. Niculescu A. Effects of in utero exposure to DES on male progeny. J Obstet Gynecol Neonatal Nurs 1985;14:468-70.

226. Pylkkanen L, Makela S, Valve E, Harkonen P, Toikkanen S, Santti R. Prostatic dysplasia associated with increased expression of c-myc in neonatally estrogenized mice. J Urol 1993;149:1593-1601.

227. Schottenfeld D, Warschauer ME, Sherlock S, Zauber AG, Leder M, Payne R. The epidemiology of testicular cancer in young adults. Am J Epidemiol 1980;112:232-46.

228. Seigler AM, Wang CF, Friberg J. Fertility of diethylstilbestrol exposed offspring [review]. Fertil Steril 1979;31:601-7.

229. Stenchever MA, Williamson RA, Leonard J, Karp LE, Ley B, Shy K, et al. Possible relationship between in utero diethylstilbestrol (DES) exposure and male infertility. Am J Obstet Gynecol 1981;140:186-93.

230. Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance in male and female offspring [review]. Am J Obstet Gynecol 1982;142:905-21.

231. Strohsnitter WC, Noller KL, Hoover RN, Robboy SJ, Palmer JR, Titus-Ernstoff L, et al. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst 2001;93(7);545-51.

232. Turusov VS, Trukhanova LS, Parfenov YD, Tomatis L. Occurrence of tumors in the descendants of CBA male mice prenatally treated with diethylstilbestrol. Int J Cancer 1992; 50:131-5.

233. Vessey MP, Fairweather DVI, Norman-Smith B, Buckley J. A randomized double-blind controlled trial of the value of diethylstilbestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Br J Obstet Gynaecol 1983;90:1007-17.

234. Vessey MP. Epidemiologic studies of the effects of diethylstilbestrol [review]. IARC Sci Publ 1989;96:335-48.

235. Whitehead ED, Leiter E. Genital abnormalities and abnormal semen analyses in males exposed to diethylstilbestrol (DES) in utero. J Urol 1981;125:47-50.

236. Wilcox AJ, Baird DD, Weinberg CR, Hornsby PP, Herbst AL. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med 1995;332:1411-6.

237. Wingard DL, Turiel J. Long-term effects of exposure to diethylstilbestrol. West J Med 1988;149(5):551-4.

238. Kaufman RH, Adam E. Findings in female offspring of women exposed in utero to diethylstilbestrol. Obstet Gynecol 2002;99:197-200.

239. Klip H, Verloop J, van Gool JD, Koster M, Burger CW, van Leeuwen FE. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 2002;359:1102-7.

240. Newbold RR, Hanson RB, Jefferson WN, Bullock BC, Haseman JA. Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis 1998;19:1655-63.

241. Newbold RR, Hanson RB, Jefferson WN, Bullock BC, Haseman J, McLachlan JA. Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis 2000;21(77):1355-63.

242. Turusov VS, Trukhanova LS, Parfenov YD, Tomatis L. Occurrence of tumors in the descendants of CBA male mice prenatally treated with diethylstilbestrol. Int J Cancer 1992;50:131-5.

243. Wilcox AJ, Umbach DM, Hornsby PP, Herbst AL. Gynecology: age at menarche among diethylstilbestrol granddaughters. Am J Obstet Gynecol 1995;173(3):835-6.

244. Ablin RJ. DES and immunologic sequelae [letter]. J Urol 1982;127(2):344.

245. Ford CD, Johnson GH, Smith WG. Natural killer cells in in utero diethylstilbestrol-exposed patients. Gynecol Oncol 1983;16:400-4.

246. Noller KL, Blair PB, O'Brien PC, Melton LJ, Offord JF, Kaufman RH, et al. Increased occurrence of autoimmune disease among women exposed in utero to DES. Fertil Steril 1988;49(6):1080-2.

247. Pietras RJ, Szego CM, Mangan CE, Seeler BJ, Burtnett MM, Orevi M. Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure. Obstet Gynecol 1978;52:321.

248. Walker BE. Animal models of prenatal exposure to DES. IARC Sci Publ 1989;96:349-64.

249. Ways SC, Mortola JF, Zvaifler NJ, Weiss RJ, Yen SS. Alterations in immune responsiveness in women exposed to DES in utero. Fertil Steril 1987;48(2):193-7.

250. Wingard DL, Turiel J. Long-term effects of exposure to DES. West J Med 1988;149(5)551-4.

251. Apfel RJ, Fisher SM. To do no harm: DES and the dilemmas of modern medicine. New Haven (CT): Yale Univ. Press; 1984.

252. Beach FA. Hormonal modification of sexually dimorphic behavior. Psychoneuroendocrinology 1975;1:3-23.

253. Burke L, Apfel RJ, Fisher S, Shaw J. Observations of the psychological impact of diethylstilbestrol exposure and suggestions on management. J Reprod Med 1980;24:99-102.

254. Ehrhardt AA, Meyer-Bahlburg HF. Effects of prenatal sex hormones on gender-related behavior. Science 1981;211:1312-8.

255. Ehrhardt AA, Meyer-Bahlburg HF, Rosen LR, Feldman JF, Veridiano NP, Zimmerman I, et al. Sexual orientation after prenatal exposure to exogenous estrogen. Arch Sex Behav 1985;14(1):57-75.

256. Ehrhardt AA, Meyer-Bahlburg HF, Rosen LR, Feldman JF, Veridiano NP, Elkin EJ, et al. The development of gender-related behavior in females following prenatal exposure to diethylstilbestrol (DES). Horm Behav 1989;23(4):526-41.

257. Fried-Cassorla M, Scholl TO, Borow LD, Strassman HD, Bowers EJ. Depression and DES exposure in women. J Reprod Med 1987;32(11):847-50.

258. Gustavson C, Gufstavson J, Noller K, O'Brien PC, Melton LJ, Pumariega AJ, et al. Increased risk of profound weight loss on women exposed to diethylstilbestrol in utero. Behav Neural Biol 1991;55:307.

259. Gutterman EM, Ehrhardt AA, Markowitz JS, Link BG. Vulnerability to stress among women with in utero diethylstilbestrol (DES) exposed daughters. J Hum Stress 1985;Fall:103-10.

260. Hines M. Prenatal gonadal hormones and sex differences in human behavior. Psychol Bull 1982;92:56-80.

261. Hines M, Sandberg EC. Sexual differentiation of cognitive abilities in women exposed to diethylstilbestrol (DES) prenatally. Horm Behav 1996;30:354-63.

262. Kester P, Green R, Finch SJ, Williams K. Prenatal "female hormone" administration and psychosexual development in human males. Psychoneuroendocrinology 1980;5:269-85.

263. Lish JD, Ehrhardt AA, Meyer-Bahlburg HF, Rosen LR, Gruen RS, Veridiano NP. Gender-related behavior development in females exposed to diethylstilbestrol (DES) in utero: an attempted replication. J Am Acad Child Adolesc Psychiatry 1991;30(1):29-37.

264. Meyer-Bahlburg HF, Ehrhardt AA, Rosen LR, Feldman JF, Veridiano NP, Zimmerman I, et al. Psychosexual milestones in women prenatally exposed to diethylstilbestrol. Horm Behav 1984;18:359-66.

265. Meyer-Bahlburg HF, Ehrhardt AA, Feldman JF, Rosen LR, Veridiano NP, Zimmerman I. Sexual activity level and sexual dysfunction in women prenatally exposed to diethylstilbestrol. Psychosom Med 1985;47(6):497-511.

266. Meyer-Bahlburg HF, Ehrhardt AA, Endicott J, Veridiano NP, Whitehead ED, Vann FH. Depression in adults with a history of prenatal DES exposure. Psychopharmacology Bull 1985;21:686-89.

267. Saunders EJ. Physical and psychological problems associated with exposure to diethylstilbestrol (DES) [review]. Hosp Community Psychiatry 1988;39(1):73-7.

268. Schwartz RW, Stewart NB. Psychological effects of diethylstilbestrol exposure. JAMA 1977;237:252-4.

269. Vessey MP, Fairweather DVI, Norman-Smith B, Buckley J. A randomized double-blind controlled trial of the value of diethylstilbestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Br J Obstet Gynaecol 1983;90:1007-17.

270. Yalom ID, Green R, Fish N. Prenatal exposure to female hormones: Effect on psychosexual development in boys. Arch Gen Psychiatry 1973;28:554-7.

271. Fertility after in utero exposure to DES [letters to the editor]. N Engl J Med 1980;303(5):280-1.

272. Guisti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995;122:778-88.

273. Herbst AL, Bern HA, editors. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. New York: Thieme-Stratton, Inc.; 1981.

274. Herbst AL. Diethylstilbestrol and other sex hormones during pregnancy [review]. Obstet Gynecol 1981;58(Suppl):35S-40S.

275. Herbst AL. The effects in the human of diethylstilbestrol (DES) use during pregnancy [review]. Int Symp Princess Takamatsu Cancer Res Fund 1987;18:67-75.

276. Noller KL, editor. DES Update. In: Clinical Practice of Gynecology. New York: Elsevier Science Publ. Co.; 1992.

277. Seigler AM, Wang CF, Friberg J. Fertility of the diethylstilbestrol exposed offspring [review]. Fertil Steril 1979;31:601-7.

278. Shapiro S, Slone D. The effects of exogenous female hormones on the fetus [review]. Epidemiol Rev 1979;1:110-23.

279. Stillman RJ. In utero exposure to diethylstilbestrol: Adverse effects on the reproductive tract and reproductive performance in male and female offspring [review]. Am J Obstet Gynecol 1982;142:905-21.

280. Swan SH. Intrauterine exposure to diethylstilbestrol: Long-term effects in humans. APMIS 2000;108:793-804.

281. Swan SH. Pregnancy outcome in DES daughters. In: Giusti RM, editor. Report of the NIH workshop on long-term effects of exposure to diethylstilbestrol (DES). Washington, DC: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1992; 42-9.

282. Thomas DB. Steroid hormones and medications that alter cancer risks [review]. Cancer 1988;62(8 Suppl):S1755-S67.

283. Vessey MP. Epidemiologic studies of the effects of diethylstilbestrol [review]. IARC Sci Publ 1989;96:335-48.

284. Williams F. Diethylstilbestrol exposure and testicular cancer [letter]. Int J Epidemiol 1989;18(2):462-3.

285. Cohn BA, Wingard DL, Patterson RC, McPhee SJ, Gerbert B. The National DES Education Program: effectiveness of the California Health Provider Intervention. J Cancer Educ 2002 Spring;17(1):40-5.

286. Department for Policy Coordination and Sustainable Development. Consolidated list of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by government. 6th ed. Pharmaceuticals. New York: United Nations; 1997.

287. Federal Drug Administration. Federal Register 1971;36:21537.

288. Jackson R, O'Donnell L, Johnson C, Dietrich AJ, Lauridsen J, O'Donnell C. Office systems intervention to improve diethylstilbestrol screening in managed care. Obstet Gynecol 2000;96(3):380-4.

289. Kaufman RH, Adam E, Haynes SG, Herbst AL, Kutzner SK, McPhee SJ, et al. Physician information: how to identify and manage DES exposed individuals. Bethesda, MD: National Cancer Institute; 1995.

290. National Cancer Institute. Exposure in utero to diethylstilbestrol and related synthetic hormones. JAMA 1976;236(10):1107-9.

291. National Cancer Institute. Cancer Facts: Questions and Answers about DES. Bethesda, MD: NCI; 2000. Available from: http://cis.nci.nih.gov/fact/3_4.htm.

292. National Cancer Institute. Dictionary. Available from http://cancer.gov/dictionary/.

293. National Institutes of Health. DES Research Update. Bethesda, MD: NIH; 1999.

294. National Cancer Institute, National Institute of Environmental Health Sciences, Office of Research on Women's Health, US Public Health Service's Office on Women's Health, Centers for Disease Control and Prevention. DES research update: Current knowledge, future directions. Proceedings. Bethesda, MD: NIH; 1999.

295. National Institutes of Health. NIH Workshop: Long-term effects of exposure to diethylstilbestrol (DES). Bethesda, MD: NIH; 1992.

296. Robboy SJ, Noller KL, Kaufman RH, Barnes AB, Townsend D, Gundersen JH, et al. Information for physicians: an atlas of findings in the human female after intrauterine exposure to diethylstilbestrol. Bethesda, MD: National Institutes of Health; 1983.

297. Wingard DL, Cohn BA, Helmrich SP, Edelstein SL. DES awareness and exposure: the 1994 California Behavioral Risk Factor Survey. Am J Prev Med 1996;12(5):437-41.

Back to Top

Contact Us | Site Map | Privacy Policy | Disclaimer | FOIA | Accessibility

CDC Home | Search | Health Topics A-Z



United States Department of Health and Human Services
Centers for Disease Control and Prevention